Intrahepatic Therapy for Liver-Dominant Metastatic Colorectal Cancer

7Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In patients with metastatic colorectal cancer, the liver is the most common site of metastatic disease. In patients with liver-dominant disease, consideration needs to be given to locoregional treatments such as hepatic arterial infusion chemotherapy, transarterial chemoembolization and selective internal radiation therapy because hepatic metastases are a major cause of liver failure especially in chemorefractory disease. In this review we provide insights on the published literature for locoregional treatment of liver metastases in metastatic colorectal cancer.

Cite

CITATION STYLE

APA

De Groote, K., & Prenen, H. (2015). Intrahepatic Therapy for Liver-Dominant Metastatic Colorectal Cancer. World Journal of Gastrointestinal Oncology, 7(9), 148–152. https://doi.org/10.4251/wjgo.v7.i9.148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free